Minims Natriumfluorescein Bausch + Lomb Ireland Limited (Fluorescein Sodium)

Fluorescein sodium binds to exposed proteins on damaged corneal epithelium. Under cobalt‑blue illumination (around 465 nm), the bound dye emits a bright green fluorescence. This contrast makes epithelial defects visible, enabling precise mapping of abrasions, ulcer margins, or areas of epithelial loss during eye examinations.

The dose of Minims Natriumfluorescein is determined by the prescribing eye‑care professional. Typically, a single drop is instilled onto the ocular surface, and the amount may be repeated if needed for adequate staining. Exact dosing frequency and volume should follow the clinician’s instructions and the product label.

Safety data for fluorescein sodium in pregnancy and lactation are limited. It is generally classified as a Category C agent, meaning it should only be used if the potential benefit justifies any potential risk to the fetus or infant. Clinicians should evaluate each case individually and discuss possible risks with the patient.

To place an order, visit the product page on gnhindia.com and submit an enquiry with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifying trade or institutional credentials before providing pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Fluorescein sodium is the most widely used ocular dye for corneal staining because of its strong fluorescence, rapid onset, and short duration of action. Alternatives such as lissamine green or rose bengal are used for different staining patterns or when fluorescein intolerance occurs. Fluorescein provides clearer visualization of epithelial defects, while the others may highlight cell death or mucous membranes.

Store Minims Natriumfluorescein at room temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from direct sunlight and moisture, and ensure the cap is tightly closed to prevent contamination. Do not freeze the solution; if the product appears discolored, discard it.

The product is administered topically to the eye. After washing hands, a single drop is placed onto the conjunctival sac of the affected eye. The clinician then examines the eye using a cobalt‑blue light source to visualize the fluorescence. Any excess dye is gently rinsed if necessary.

Serious risks, although rare, include severe allergic reactions such as anaphylaxis or angioedema, corneal toxicity with prolonged exposure, and a possible increase in intra‑ocular pressure. Patients should be monitored for signs of systemic allergy, persistent irritation, or visual changes, and immediate medical attention should be sought if these occur.

Minims Natriumfluorescein should not be used in individuals with a known hypersensitivity to fluorescein sodium or any of the formulation’s excipients. It is also contraindicated in eyes with active severe infections or uncontrolled inflammation where dye application could exacerbate the condition. Clinicians must assess each patient’s medical history before use.